In accordance with these findings, our genome-wide analysis of mRNA expressions in CD4+ T cells and subsequent qRT-PCR validation of microarray results both revealed that CD40L was significantly upregulated in SLE patients, indicating it as a pathogenic factor in SLE. The gene discussed is CD40LG; the disease is systemic lupus erythematosus.